Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 601–700 of 1,006
Control of Intracellular Calcium Signaling as a Neuroprotective Strategy
Duncan, R. S., Goad, D. L., Grillo, M. A., Kaja, S., Payne, A. J., & Koulen, P. (2010) · Molecules · doi:10.3390/molecules15031168 · Cited by 68
“Treatment of cortical neurons with Aβ1-42 peptide increases endocytosis of NMDA receptor subunits (NR1 and NR2B) [98].”
Mokhtar, S., Bakhuraysah, M. M., Cram, D. S., & Petratos, S. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/910502 · Cited by 87
Regulation of NR1/NR2C N-Methyl-D-aspartate (NMDA) Receptors by Phosphorylation*
Chen, B.-S., Braud, S., Badger, J. D., Isaac, J. T. R., & Roche, K. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513029200 · Cited by 64
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly
Sokolow, S., Henkins, K. M., Bilousova, T., Miller, C. A., Vinters, H. V., Poon, W., Cole, G. M., & Gylys, K. H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.011 · Cited by 58
Sinnen, B. L., Bowen, A. B., Gibson, E. S., & Kennedy, M. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1603-16.2016 · Cited by 66
“…et al., 2007; Alberdi et al., 2010), whereas others provide evidence for loss of NMDAR function by removal from the cell surface and activation of synaptic depression signaling pathways (Snyder et al., 2005; Shankar et al., 2007, 2008; Kurup et al., 2010; Jo et al., 2011; Tamburri et al., 2013).”
InfluentialDomingues, A. M. D. J., Almeida, S., DACRUZESILVA, E., Oliveira, C. R., & Rego, A. C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.001 · Cited by 67
Lilja, A. M., Porras, O., Storelli, E., Nordberg, A., & Marutle, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101242 · Cited by 57
Green tea extract enhances parieto-frontal connectivity during working memory processing
Schmidt, A., Hammann, F., Wölnerhanssen, B., Meyer-Gerspach, A. C., Drewe, J., Beglinger, C., & Borgwardt, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3526-1 · Cited by 57
“Furthermore, amyloid protein impairs synaptic plasticity by modulating an NMDA-type glutamate receptor-dependent signaling pathway (Shankar et al. 2007; Snyder et al. 2005).”
Pankiewicz, J. E., Guridi, M., Kim, J., Asuni, A. A., Sanchez, S., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0075-0 · Cited by 74
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
Jeong, H., Shin, H., Hong, S., & Kim, Y. S. (2022) · Experimental Neurobiology · doi:10.5607/en22004 · Cited by 65
“Given that NMDARs can promote LTP or LTD depending on the intracellular Ca2+ concentration [92], it is possible that Aβ at picomolar concentrations may also have a physiologically normal interaction with NMDARs, though 70 www.enjournal.org https://doi.org/10.5607/en22004 related investigations are currently lacking to…”
InfluentialMechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 63
Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease
Jürgensen, S., & Ferreira, S. T. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9237-0 · Cited by 69
“Chen et al. (2006) found that Aβ-infused rats exhibited a depression of post-tetanic potentiation, paired-pulse facilitation, and LTP, which was accompanied by a decline in responsiveness to the selective α7 nAChR agonist, 3-(2,4-dimethoxybenzylidene)-anabaseine, suggesting that Aβ-induced inhibition of α7 nAChRs led…”
Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK‐801
Siddiqui, A., Lacroix, T., Stasko, M. R., Scott‐McKean, J. J., Costa, A. C. S., & Gardiner, K. J. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00428.x · Cited by 57
Krogh, K. A., Wydeven, N., Wickman, K., & Thayer, S. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12724 · Cited by 58
Calcium in the initiation, progression and as an effector of Alzheimer’s disease pathology
Green, K. N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00861.x · Cited by 57
“What is the consequence of A , or A oligomers, associating with NMDA receptors at synapses? It appears that A may have a physiological role in regulating synaptic plasticity via the NMDA receptor, as A secreted from synapses causes NMDA receptor dependent synaptic depression [52], which could arise due to increased en…”
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress
Celsi, F., Svedberg, M., Unger, C., Cotman, C. W., Carrì, M. T., Ottersen, O. P., Nordberg, A., & Torp, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.022 · Cited by 57
“It has also been shown that calcineurin can be activated by Aβ peptides, via increase of intracellular Ca mediated by α7 nicotinic receptor (Snyder et al., 2005).”
BackgroundSynaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O'Leary, V. B., Zaborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
“the synaptic effects of Ab have been focusing on the postsynaptic side, with impairments of N-methyl-Daspartate [126], metabotropic glutamate receptor 5 [109], and M1 muscarinic cholinergic [37] receptors as well as deregulation of insulin and insulin growth factors [77], ephrin [24] and neurotrophin signaling [26,90].”
Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss
Burrinha, T., Martinsson, I., Gomes, R., Terrasso, A. P., Gouras, G. K., & Almeida, C. G. (2021) · Journal of Cell Science · doi:10.1242/jcs.255752 · Cited by 64
“Formins and the Arp2/3 complex promote local F-actin polymerization during endocytic vesicle formation (Hinze and Boucrot, 2018; Soykan et al., 2017).”
Self-citationNFATs and Alzheimer's Disease.
Abdul, H. M., Furman, J. L., Sama, M. A., Mathis, D. M., & Norris, C. M. (2010) · PubMed · Cited by 63
β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices
Kabogo, D., Rauw, G. A., Amritraj, A., Baker, G. B., & Kar, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.009 · Cited by 64
Presenilin/γ‐secretase activity regulates protein clearance from the endocytic recycling compartment
Zhang, M., Haapasalo, A., Kim, D. Y., Ingano, L. A. M., Pettingell, W. H., Kovacs, D. M., Zhang, M., Haapasalo, A., Kim, D. Y., Ingano, L. A. M., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5531fje · Cited by 57
“shown to be regulated by synaptic A levels (96, 97).”
Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
Roy, J., Tsui, K. C., Ng, J., Fung, M., & Lim, L. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136841 · Cited by 63
Ortiz-Sanz, C., Balantzategi, U., Quintela‐López, T., Ruiz, A., Luchena, C., Zuazo-Ibarra, J., Capetillo‐Zarate, E., Matute, C., Zugaza, J. L., & Alberdi, E. M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04687-y · Cited by 63
Intracellular calcium signalling in Alzheimer’s disease
Hermes, M., Eichhoff, G., & Garaschuk, O. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00976.x · Cited by 56
“Further studies in mutant mice have shown that elevated A levels result in spine loss [17, 99–101], reduction in the number of excitatory synapses [102] and depressed glutamatergic synaptic transmission [103, 104] accompanied by glutamate receptor endocytosis [104, 105].”
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 59
“Ab interferes with normal NMDAR trafficking and reduces the number of surface NMDAR (Snyder et al. 2005).”
Origlia, N., Criscuolo, C., Arancio, O., Yan, S. S., & Domenici, L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0141-14.2014 · Cited by 56
“, 2008, 2009a), whereas higher micromolar concentrations caused synaptic depression and LTD impairment (Snyder et al., 2005; Hsieh et al., 2006; Parameshwaran et al., 2007; Origlia et al., 2010).”
Babri, S., Mohaddes, G., Feizi, I., Mohammadnia, A., Niapour, A., Alihemmati, A., & Amani, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.018 · Cited by 61
The ethics of elective psychopharmacology
Mohamed, A. D., & Sahakian, B. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100037x · Cited by 65
“This promotes the phosphorylation of CREB that slows down the pathological changes observed in AD (Snyder et al. 2005).”
BackgroundBai, Y., Li, M., Zhou, Y., Ma, L., Qiao, Q., Hu, W., Li, W., Wills, Z. P., & Gan, W.-B. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0228-2 · Cited by 56
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Xiong, Y., & Lim, C. (2021) · Brain Sciences · doi:10.3390/brainsci11091211 · Cited by 62
“Moreover, Aβ can promote endocytosis of NMDA receptors to suppress synaptic transmission [10,11].”
Siddappaji, K. K., & Gopal, S. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021020 · Cited by 66
“Abbreviations: AD: Alzheimer’s disease; Aβ: Amyloid-beta; NFTs: Neurofibrillary Tangles; APP: Amyloid Precursor Protein; sAPPα: soluble Amyloid Precursor Protein alpha; AICD: Amyloid Precursor Protein Intra Cellular Domain; NMDAR: N-Methyl-D-Aspartate Receptor; AMPAR: α-Amino-3-hydroxy-5-Methyl-4-isoxazole Propionic a…”
BackgroundShehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
“Aβ1-42 increases the release of glutamate and decreases γ-aminobutyric acid (GABA) release, which causes excitationinhibition imbalance and induces glutamate excitotoxicity.(191,192) Donepezil activates and upregulates α4- and α7-nAChRs that provide neuroprotection against Aβ- and glutamate-induced neurotoxicity.”
Zhang, Y., Kurup, P., Xu, J., Anderson, G. M., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07450.x · Cited by 55
Self-citationThe role of proteases in regulating Eph/ephrin signaling
Atapattu, L., Lackmann, M., & Janes, P. W. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.970026 · Cited by 69
“Interestingly, unlike ephrin-B2, the effect of EphB2 CTF on NMDAR phosphorylation is apparently direct and independent of Src,130 NMDA receptor signaling is also implicated in Alzheimer’s disease (AD), and these potential functions may be impaired by familial AD mutations in PS1 that inhibit production of both ephrin-…”
Contribution of neural networks to Alzheimer disease's progression
Savioz, A., Leuba, G., Vallet, P. G., & Walzer, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.006 · Cited by 55
Mohmmad Abdul, H., Baig, I., LeVine 3rd, H., Guttmann, R. P., & Norris, C. M. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00645.x · Cited by 54
“, 2009) and negate many of the neurotoxic actions of Ab (Chen et al., 2002; Cardoso & Oliveira, 2005; Snyder et al., 2005; Shankar et al., 2007; Reese et al., 2008; Abdul et al., 2009; Li et al., 2009; Wu et al., 2010).”
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 54
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 64
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Park, J., Jang, M., & Chang, S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.004 · Cited by 54
“…expression of 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid (AMPA) and N-methyl-D-aspartic acid (NMDA) receptors, and disturbing calcium homeostasis (Demuro et al., 2005; Green and LaFerla, 2008; Haass and Selkoe, 2007; Hsieh et al., 2006; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundAndreoli, V., Marco, E. V. D., Trecroci, F., Cittadella, R., Palma, G. D., & Gambardella, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1125-7 · Cited by 60
Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β
Wang, Z.-C., Zhao, J., & Li, S. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1383-2 · Cited by 54
Kina, S., Tezuka, T., Kusakawa, S., Kishimoto, Y., Kakizawa, S., Hashimoto, K., Ohsugi, M., Kiyama, Y., Horai, R., Sudo, K., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05829.x · Cited by 56
“Currents through NMDARs are potentiated by Src-family PTKs. Tyrosine dephosphorylation of NMDARs is implicated in receptor internalization (Snyder et al., 2005).”
BackgroundDinamarca, M. C., Weinstein, D., Monasterio, O., & Inestrosa, N. C. (2011) · Biochemistry · doi:10.1021/bi201246t · Cited by 54
Jurcau, A. (2021) · Nutrients · doi:10.3390/nu13020282 · Cited by 54
“receptors, the expression of Aβ further reduces the amount of surface NMDA receptors and, by binding of soluble Aβ to AMPA receptors, promotes the internalization of the latter leading to synaptic dysfunction, loss of dendritic spines, and affecting synaptic plasticity [54,55].”
Tau acts as a mediator forAlzheimer's disease‐related synaptic deficits
Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53
“initiated by increased Ab levels (Hsieh et al., 2006; Kamenetz et al., 2003; Shankar et al., 2007; Snyder et al., 2005) and tau mislocalization due to tau mutation (Hoover et al.”
InfluentialProtection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine
Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69
“…vitro and in vivo (Domingues et al., 2007; Kelly nd Ferreira, 2006; Molnar et al., 2004; Szegedi et al., 2005; u et al., 1995) but see, for example, Snyder et al. (2005). lternatively, or in addition, A may increase endogenous lutamate concentration at NMDARs by inhibiting glutamate ptake or…”
BackgroundMurakami, K. (2014) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2014.940275 · Cited by 53
AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases
Qin, S., Tang, H., Li, W., Gong, Y., Li, S., Huang, J., Fang, Y., Yuan, W., Liu, Y., Wang, S., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200523172334 · Cited by 53
Tuo, W., Wang, S., Shi, Y., Cao, W., Liu, Y., Su, Y., Xiu, M., & He, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124639 · Cited by 56
Synaptic Compensatory Plasticity in Alzheimer’s Disease
Bhembre, N., Bonthron, C., & Opazo, P. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-23.2023 · Cited by 59
APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer’s disease
Tian, Q., Li, J., Wu, B., Pang, Y., He, W., Xiao, Q., Wang, J., Yi, L., Tian, N., Shi, X., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184656 · Cited by 63
Khundakar, A. A., & Thomas, A. J. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-148003 · Cited by 53
Dabrowska, J., Hazra, R., Guo, J.-D., Li, C., DeWitt, S., Xu, J., Lombroso, P. J., & Rainnie, D. G. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.032 · Cited by 53
Self-citationIreland, D. R., & Abraham, W. C. (2009) · Journal of Neurophysiology · doi:10.1152/jn.90643.2008 · Cited by 53
“For example, NMDAR activity and trafficking are regulated by both src family PTKs (Kohr and Seeburg 1996; Yu and Salter 1999) and STEP (striatal enriched tyrosine phosphatase) (Braithwaite et al. 2006; Pelkey et al. 2002; Snyder et al. 2005).”
Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases
Schverer, M., Lanfumey, L., Baulieu, É.-É., Froger, N., & Villey, I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.011 · Cited by 62
“This effect is probably the result of NMDA receptor signaling and/or protein kinase A/c-AMP response element-binding protein pathway inhibition (Shankar et al., 2007; Snyder et al., 2005; Vitolo et al., 2002).”
BackgroundCook, S. G., Goodell, D. J., Restrepo, S., Arnold, D. B., & Bayer, K. U. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.041 · Cited by 53
“It is well described that Ab causes the internalization of NMDA receptors (Jo et al., 2011; Kurup et al., 2010; Shankar et al., 2008; Sinnen et al., 2016; Snyder et al., 2005), a mechanism that would be expected to inhibit the synaptic translocation of CaMKII that is mediated by binding to the receptor.”
BackgroundCreus‐Muncunill, J., & Ehrlich, M. E. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00782-9 · Cited by 57
Quartey, M. O., Nyarko, J. N. K., Maley, J. M., Barnes, J. R., Bolanos, M. A. C., Heistad, R. M., Knudsen, K. J., Pennington, P. R., Buttigieg, J. A., de Carvalho, C. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80164-w · Cited by 65
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 56
Singer, S. J., & Dewji, N. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509892103 · Cited by 57
Zhang, H., Zhang, L., Zhou, D., He, X., Wang, D., Pan, H., Zhang, X., Mei, Y., Qian, Q., Zheng, T., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.001 · Cited by 52
Elnagar, M. R., Walls, A. B., Helal, G. K., Hamada, F. M. A., Thomsen, M. S., & Jensen, A. A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.047 · Cited by 54
Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases
LoPachin, R. M., Gavin, T., & Barber, D. S. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.04.016 · Cited by 57
VEGF counteracts amyloid-β-induced synaptic dysfunction
Martin, L., Bouvet, P., Chounlamountri, N., Watrin, C., Besançon, R., Pinatel, D., Meyronet, D., Honnorat, J., Buisson, A., Salin, P. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109121 · Cited by 54
Taniguchi, K., Yamamoto, F., Amano, A., Tamaoka, A., Sanjo, N., Yokota, T., Kametani, F., & Araki, W. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.03.001 · Cited by 60
Spires-Jones, T. L., Kay, K., Matsouka, R., Rozkalne, A., Betensky, R. A., & Hyman, B. T. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.033 · Cited by 51
“Upregulation of calcineurin activity has also been implicated in Alzheimer disease models, where it is believed to be important for amyloid-beta induced loss of glutamate receptors and dendritic spine loss [2,16,27,31].”
C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β
Andreyeva, A., Nieweg, K., Horstmann, K., Klapper, S., Müller-Schiffmann, A., Korth, C., & Gottmann, K. (2012) · Brain · doi:10.1093/brain/aws120 · Cited by 51
“In addition, the synaptic expression of NMDA receptors has been described to be reduced by amyloid-b peptides (Snyder et al., 2005; Hsieh et al., 2006; Dewachter et al., 2009), thus potentially shifting synaptic NMDA receptor function from bidirectional plasticity to the induction of long-term…”
BackgroundNeuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain
Patel, A. N., & Jhamandas, J. H. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002134 · Cited by 43
Amyloid-Beta Mediates Homeostatic Synaptic Plasticity
Galanis, C., Fellenz, M., Becker, D., Bold, C., Lichtenthaler, S. F., Müller, U. C., Deller, T., & Vlachos, A. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1820-20.2021 · Cited by 51
“Consistent with previous work on Hebbian plasticity (Gu et al., 2009; Sinnen et al., 2016; Snyder et al., 2005; Zhang et al., 2009; Zhao et al., 2004), we could link the homeostatic plasticity effects of Aβ to NMDA-Rs and CamKII.”
BackgroundGoebel-Goody, S. M., Alvestad, R. M., Coultrap, S. J., & Browning, M. D. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.09.012 · Cited by 56
Dynamics and function of distal regulatory elements during neurogenesis and neuroplasticity
Thakurela, S., Sahu, S. K., Garding, A., & Tiwari, V. K. (2015) · Genome Research · doi:10.1101/gr.190926.115 · Cited by 50
“Moreover, neurotoxicity induced via hyper-stimulation of the NMDA receptor also facilitates slow-progressing neurodegenerative diseases (e.g., Huntington ’ s, Alz-heimer ’ s, Parkinson ’ s, and amyotrophic lateral sclerosis) (Young et al. 1988; Ulas et al. 1994; Ikonomidou et al. 1996; Blanchet et al. 1997; Snyder et…”
Arnsten, A. F. T., & Wang, M. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103617 · Cited by 50
“However, it is important to note that nic-α7R agonists may not be appropriate for cognitive disorders in the aged, as evidence from mouse models of AD suggests that nic-α7R stimulation can cause NMDAR internalization in the presence of beta amyloid (Aβ) oligomers (113).”
LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype
Maier, W., Bednorz, M., Meister, S., Roebroek, A., Weggen, S., Schmitt, U., & Pietrzik, C. U. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-25 · Cited by 50
“NMDA receptors is a prerequisite for normal NMDA receptor activity [24,29,30].”
Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Zhang, X., Wang, D., Zhang, B., Zhu, J., Zhou, Z., & Cui, L. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.001 · Cited by 56
Li, W., Jia, Y., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4610-12.2013 · Cited by 54
“A previous study suggested that downregulation of NMDARs by exogenous A is likely mediated by overactivation of calcineurin (Snyder et al., 2005).”
InfluentialRetractedDisordered Proteins: Biological Membranes as Two-Dimensional Aggregation Matrices
Byström, R., Aisenbrey, C., Borowik, T., Bokvist, M., Lindström, F., Sani, M., Olofsson, A., & Gröbner, G. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9033-4 · Cited by 50
“And the biochemical process behind an altered memory function might be connected to synaptic and neuronal membranes, both been able to bind amyloid oligomers [11, 129].”
Proctor, D. T., Coulson, E. J., & Dodd, P. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.02.002 · Cited by 60
“1; Snyder et al., 2005).”
Lanznaster, D., Mack, J. M., Coelho, V., Ganzella, M., Almeida, R. F., Dal-Cim, T. A., Hansel, G., Zimmer, E. R., Souza, D. O., Prediger, R. D., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0082-1 · Cited by 53
How the shapes of seeds can influence pathology
Melki, R. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.011 · Cited by 50
Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
Vallée, A., Vallée, J.-N., Guillevin, R., & Lecarpentier, Y. (2020) · Aging · doi:10.18632/aging.102830 · Cited by 52
“Excessive activation of extra-synaptic NMDA receptors [63]and excessive downregulation of synaptic NMDA receptors [64] lead to increase of Aβ release [65].”
Kervern, M., Angeli, A., Nicole, O., Léveillé, F., Parent, B., Villette, V., Buisson, A., & Dutar, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120394 · Cited by 63
Alberghina, L., & Colangelo, A. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-s1-s2 · Cited by 55
“In fact, Aβ-mediated cleavage of AMPA subtype of glutamate receptors has been shown to occur in a caspase-dependent manner both in AD brains and in cultured neurons [124], while recently Aβ has been found to promote the endocytosis of NMDA receptors through a mechanism involving Ca2+ influx and dephosphorylation of th…”
BackgroundSoler‐López, M., Badiola, N., Zanzoni, A., & Aloy, P. (2012) · BioEssays · doi:10.1002/bies.201100193 · Cited by 50
“Additionally, the increase in intracellular free calcium would directly affect the efflux through ER Ca2þ-receptors in synaptic terminals, compromising synaptic transmission [74, 75] and exacerbating Ab-mediated excitotoxicity through Nmethyl-D-aspartate (NMDA) receptors [76].”
STAT1 Negatively Regulates Spatial Memory Formation and Mediates the Memory-Impairing Effect of Aβ
Hsu, W.-L., Ma, Y.-L., Hsieh, D.-Y., Liu, Y.-C., & Lee, E. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.263 · Cited by 49
“Thus, the NR1 and NR2B bands were observed in the overexpression groups only (Figure 7d).”
InfluentialPellistri, F., Bucciantini, M., Relini, A., Nosi, D., Gliozzi, A., Robello, M., & Stefani, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803992200 · Cited by 49
Wang, H.-Y., Bakshi, K. P., Shen, C., Frankfurt, M., Trocmé, C., & Morain, P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.031 · Cited by 55
β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3
Deng, Y., Xiong, Z., Chen, P., Wei, J., Chen, S., & Yan, Z. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.031 · Cited by 49
“In contrast, reduced amounts of surface NMDA receptors have been found in 12-day-old cultured neurons from APP mice, and decreased NMDAR currents by Ab treatment (5 minutes) have been found in a subset of neurons (Snyder et al., 2005).”
BackgroundKam, T.-I., Park, H., Gwon, Y., Song, S., Kim, S.-H., Moon, S. W., Jo, D.-G., & Jung, Y.-K. (2016) · eLife · doi:10.7554/elife.18691 · Cited by 49
Jeon, S. G., Kang, M., Kim, Y. S., Kim, D.-H., Nam, D. W., Song, E. J., Mook‐Jung, I., & Moon, M. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.302 · Cited by 50
Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 55
Self-citationGoto, Y., Niidome, T., Akaike, A., Kihara, T., & Sugimoto, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.030 · Cited by 56
Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic mice
West, M. J., Bach, G., Søderman, A., & Jensen, J. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.009 · Cited by 48
“Aducanumab” making a comeback in Alzheimer’s disease: An old wine in a new bottle
Behl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Makeen, H. A., Albratty, M., Alhazmi, H. A., Felemban, S. G., Alsubayiel, A. M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112746 · Cited by 50
Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities
Li, S., & Stern, A. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01589-5 · Cited by 51
Hsiao, Y., Chen, P. S., Chen, S., & Gean, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.69 · Cited by 49
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 60
Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
Yao, L., & Zhou, Q. (2017) · Neural Plasticity · doi:10.1155/2017/2875904 · Cited by 54
Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases
Song, Z., Zhou, Y., Han, X., Qin, J., & Tang, X. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02745f · Cited by 48
Striatal‐enriched protein tyrosine phosphatase regulates the PTP α/Fyn signaling pathway
Xu, J., Kurup, P., Foscue, E., & Lombroso, P. J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13160 · Cited by 47
Self-citation
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.